HemaSphere (Jun 2018)

The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered

  • Peter Borchmann,
  • Alexander Fosså,
  • Monika Długosz-Danecka,
  • Boris Böll,
  • Markus Dietlein,
  • Carsten Kobe,
  • Helen Goergen,
  • Andreas Engert

DOI
https://doi.org/10.1097/HS9.0000000000000052
Journal volume & issue
Vol. 2, no. 3

Abstract

Read online

No abstracts available.